Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI
- 21 August 2022
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115661
Abstract
No abstract availableKeywords
Funding Information
- Collaborative Innovation Project of Colleges and Universities of Anhui Province (GXXT-2020-017)
This publication has 62 references indexed in Scilit:
- Role of Extracellular Adenosine in Acute Lung InjuryPhysiology, 2009
- Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activationRespiratory Research, 2009
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosaMucosal Immunology, 2008
- Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusionThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Specific Inhibition of Nuclear Factor-κB–Dependent Inflammatory Responses by Cell Type-Specific Mechanisms upon A2A Adenosine Receptor Gene TransferMolecular Pharmacology, 2004
- Adenosine suppresses activation of nuclear factor-κB selectively induced by tumor necrosis factor in different cell typesOncogene, 2003
- Points of control in inflammationNature, 2002
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonistsBritish Journal of Pharmacology, 2001